← Browse by Condition
Medical Condition
advanced malignant solid neoplasm
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 2
NCT04704661 Phase 1
Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Enrollment
51 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT04984551 Phase 2
Recruiting
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
Enrollment
312 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06438588
Recruiting
Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial
Enrollment
10 pts
Location
United States
Sponsor
Mayo Clinic
NCT05053971 Phase 1, Phase 2
Recruiting
Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
Enrollment
49 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT04693468 Phase 1
Recruiting
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
Enrollment
111 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center